Philly Judge Junks J&J Risperdal Case Midtrial

Law360, Philadelphia (December 13, 2016, 5:38 PM EST) -- A midtrial ruling by a Philadelphia judge rejecting expert causation testimony brought a premature end Tuesday to the latest case over allegations that the Johnson & Johnson antipsychotic drug Risperdal caused an adolescent boy to grow female breasts.

Judge Sean Kennedy in the Philadelphia County Court of Common Pleas ruled from the bench on Tuesday morning that expert testimony offered by Mark Solomon could not support claims that Risperdal caused Tommy Moroni to develop breasts after he began taking the powerful antipsychotic as a 7-year-old boy...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.